Brad Perriello

Japanese regulators approved TransEnterix‘s Senhance robot-assisted surgery device for several procedures. Japan’s Ministry of Health, Labor & Welfare granted “shonin” approval to Senhance for laparoscopy for general surgery, gynecology, urology and “certain thoracic procedures,” the Research Triangle Park, N.C.-based company said. “Regulatory approval in Japan is a pivotal milestone for our company, as Japan is…

HistoSonics closed a $54 million Series C round for its robotically-assisted platform it says uses sound energy to liquify and destroy cancerous tumors without affecting surrounding tissue. Branded as Robotically Assisted Sonic Therapy (RAST), the histotripsy technology combines robotics, imaging and sensor technology to exploit microscopic air bubbles that naturally exist in tissue. HistoSonics’ Series…

Intuitive Surgical won another indication from the Food and Drug Administration (FDA) for its da Vinci SP robot-assisted surgery device. The Sunnyvale, Calif.-based company said the FDA added single-port radical tonsillectomy and tongue base resection procedures to the mix. Initially cleared in April 2014 for urological procedures, in June 2018 the federal safety watchdog added a clearance…

Stryker Corp. said today that it is acquiring OrthoSpace Ltd. and its InSpace rotator cuff repair device for $220 million. Kalamazoo, Mich.-based Stryker said it paid $110 million in cash upfront and agreed to another $110 million in potential milestones for Caesarea, Israel-based OrthoSpace. “The acquisition of OrthoSpace is highly complementary to our existing portfolio…

Keynotes | Speakers | Exhibitors | Register Think Surgical has raised a funding round worth $134 million for its robot-assisted orthopedic surgery device. Based in Fremont, Calif., Think Surgical’s TSolution One is designed for knee and hip arthroplasties. The TSolution One is approved in the U.S. and Europe for total hip procedures; in December 2017…

Medtronic has closed the $1.7 billion acquisition of Mazor Robotics and its robot-assisted surgery platform. Medtronic capped the buyout with the announcement that its first jointly produced product won an FDA nod. Last month Caesarea, Israel-based Mazor said its shareholders voted to approve the $58.50-per-ADR-share deal with the world’s largest medical device maker, which has…

Medtronic has owned since 2016 a $300 million stake (about 11%) in Mazor, which is widely regarded as a leader in robot-assisted spine surgery. By 2022, the global spinal surgical robotics market is expected to reach $2.77 billion. Mazor makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform. Medtronic became the…

Procept BioRobotics has raised $118 million in an equity round. The Redwood Shores, Calif.-based company plans to use the funding on the commercialization of its Aquablation robotic prostate surgery for benign prostate hyperplasia. Procept said new backer Viking Global Investors led the round, joined by Perceptive Advisors and existing investors including CPMG. The Aquablation treatment…

Procept BioRobotics said today that it won de novo clearance from the FDA for its Aquabeam device for treating benign prostate hyperplasia, saying it plans to have the device on the U.S. market early next year. Redwood Shores, Calif.-based Procept said the federal safety watchdog used the 181-patient Water study to inform its decision. The trial, comparing Aquablation…

TransEnterix (NYSE:TRXC) said today that it agreed to deal its SurgiBot assets to Chinese medtech investment firm Great Belief International for $29 million. The agreement calls for Research Triangle Park, N.C.-based TransEnterix to retain the distribution rights to SurgiBot, which it shelved last year, outside of the U.S. The FDA in April 2016  denied 510(k) clearance for…

Medical robotics startup Robocath said today that it added about $2 million (€1.7 million) to the more than $5 million it raised earlier this year, taking its total to $7.5 million in funding this year. Rouen, France-based Robocath, which is developing the R-One robotic platform for coronary angioplasty, is pursuing CE Mark approval in the European Union for…

Titan Medical (TSX:TMD) said today that it closed a funding round that brought in nearly $4 million more than it was originally expecting, grossing more than $18 million for the Sport robot-assisted surgery device it’s developing. Last month the Toronto-based company upsized the previously announced offering to between $14.1 million and $18 million ((C$18 million to C$23 million), up…

TransEnterix (NYSE:TRXC) shares jumped today after the medical device company said it sold its first Senhance robot-assisted surgery platform in the U.S., exactly a month after winning FDA clearance. The sale, to Florida Hospital in Orlando, follows another sale in Taiwan made during the third quarter, president & CEO Todd Pope said during a conference call…

Mazor Robotics (NSDQ:MZOR) today reported third-quarter results that blew past the consensus forecast on Wall Street, more than doubling sales and paring its losses by more than 30%. The Caesarea, Israel-based robot-assisted surgery company posted losses of -$3.7 million, or -7¢ per share, on sales of $17.2 million for the three months ended Sept. 30, cutting…

Procept BioRobotics said today that it launched a clinical trial aimed at winning reimbursement approval in France for its AquaBeam prostate treatment. Redwood Shores, Calif.-based Procept said the 30-patient Francais Water study is designed to evaluate the safety and effectiveness of prostate ablation via waterjet in treating benign prostate hyperplasia in men aged 45 to 80.…

Robot-assisted surgery startup Riverfield Surgical Robot Laboratory reportedly raised more than $10 million (¥1.15 billion) for the Emaro robot-assisted surgery platform it’s developing. Based on technology developed at the Tokyo Institute of Technology, Riverfield plans to have its device on the Japanese market by 2020, selling at half the price of the da Vinci robot…

A Massachusetts startup is planning to capitalize on the lucrative demand for the guts of robots instead of the robots themselves. Veo Robotics is developing the software and sensors for industrial robots, a product focus the Cambridge company calls the “brains for robotic systems.” The cost of software, peripherals and systems engineering can account for…

Share prices for TransEnterix (NYSE:TRXC) have more than doubled since the robot-assisted surgery company won an important clearance from the FDA last week and CEO Todd Pope is optimistic about his companies chances against the undisputed market leader, Intuitive Surgical (NSDQ:ISRG). Morrisville, N.C.-based TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last…

TransEnterix (NYSE:TRXC) said last week that it won 510(k) clearance from the FDA for its Senhance robot-assisted surgery platform. TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last month after applying in April.  “The clearance of the Senhance system in the U.S. is a milestone in the progress of robotics and is…

Mazor Robotics (NSDQ:MZOR) shares ticked up today after the Israeli robot-assisted surgery company reported its preliminary sales numbers for the third quarter. Caesarea, Israel-based Mazor, which last month closed a third, $40 million tranche as part of its deal with Medtronic (NYSE:MDT), said it expects to post sales of $17.2 million for the 3 months ended…

TransEnterix (NYSE:TRXC) last week won the dismissal of a shareholders lawsuit brought over the collapse of its SurgiBot program, with a federal judge ruling that the company and its management and investors didn’t mislead shareholders about the robot-assisted surgery platform’s prospects with the FDA. The case dates back to the spring of 2016, when Research Triangle Park,…

Business-to-Business publisher WTWH Media, LLC today announced the selection of Boston for the inaugural Robotics Summit & Expo 2018. The Robotics Summit & Expo will feature an in-depth technology conference and exposition along with a unique Investor Forum to provide insight and forecasting for investor opportunities in robotics. The Summit is a brand extension of The Robot…